{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-052750","form_type":"8-K12G3","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2025-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.202380+00:00","generated_at":"2026-05-20T10:50:15.870898+00:00","sec_items":["1.01","3.03","8.01","5.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BeiGene completes redomestication to Switzerland, renamed BeOne Medicines Ltd.","bullets":["Effective May 27, 2025, BeiGene continued from Cayman Islands to Switzerland, becoming BeOne Medicines Ltd.","New Swiss Articles and Organizational Regulations govern shareholder rights; ADSs continue on Nasdaq under ONC.","Executive employment agreements executed with CEO Oyler ($1.133M base), President Wu (RMB 6.0M), CFO Rosenberg ($660K), R&D head Wang (RMB 4.59M), and GC Lee ($654K).","Amended deposit agreement with Citibank and new indemnification agreements for directors and officers adopted.","Ordinary shares listed on HKEX (06160) and Shanghai STAR Market (688235) remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-052750","json":"https://secwatch.observer/filing/0001104659-25-052750.json","markdown":"https://secwatch.observer/filing/0001104659-25-052750.md","text":"https://secwatch.observer/filing/0001104659-25-052750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925052750/0001104659-25-052750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925052750/tm2515777d13_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T10:50:15.870898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19c867b9ed239717cafd6ac92bfac679f4cb7dc7","claim":"BeOne Medicines Ltd.: Company continued from Cayman Islands to Switzerland; adopted Swiss Articles and Organizational Regulations, replacing the prior Seventh Amended and Restated Memorandum and Articles of Association (effective 2025-05-27).","evidence_excerpt":"The Swiss Articles and Organizational Regulations became effective as of May 27, 2025 in connection with the Continuation.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925052750/0001104659-25-052750-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}